Literature DB >> 2231682

Mutational analysis of simian immunodeficiency virus from African green monkeys and human immunodeficiency virus type 2.

R Shibata1, A Adachi, H Sakai, A Ishimoto, T Miura, M Hayami.   

Abstract

We constructed ten mutants of simian immunodeficiency virus isolated from African green monkey (SIVAGM), and nine mutants of human immunodeficiency virus type 2 (HIV-2) in vitro. Their infectivity, cytopathogenicity, transactivation potential, virus RNA, and protein synthesis were examined by transfection and infection experiments. Mutations in three structural (gag, pol, env) and two regulator (tat, rev) genes abolished the infectivity of both viruses, but vpx, vpr (HIV-2), and nef were dispensable and mutant viruses were indistinguishable phenotypically from wild type virus. A vif mutant of HIV-2 showed poor infectivity in cell-free condition, whereas SIVAGM mutants grew equally well with wild type virus. In transient transfection assays, rev mutants derived from both viruses produced mainly small mRNA species and no detectable virus proteins and particles. Transactivation potential of tat mutants originated from both viruses was about three- to ten-fold less than that of respective wild type DNAs, generating small amounts of virus.

Entities:  

Mesh:

Year:  1990        PMID: 2231682

Source DB:  PubMed          Journal:  J Med Primatol        ISSN: 0047-2565            Impact factor:   0.667


  4 in total

1.  Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity.

Authors:  D L Lichtenstein; K E Rushlow; R F Cook; M L Raabe; C J Swardson; G J Kociba; C J Issel; R C Montelaro
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

2.  Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1.

Authors:  D N Levy; Y Refaeli; R R MacGregor; D B Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

3.  Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency.

Authors:  D N Levy; Y Refaeli; D B Weiner
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

Review 4.  Feline APOBEC3s, Barriers to Cross-Species Transmission of FIV?

Authors:  Zeli Zhang; Qinyong Gu; Daniela Marino; Kyeong-Lim Lee; Il-Keun Kong; Dieter Häussinger; Carsten Münk
Journal:  Viruses       Date:  2018-04-10       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.